Literature DB >> 22540673

Population dynamics and the evolution of antifungal drug resistance in Candida albicans.

Mian Huang1, Katy C Kao.   

Abstract

Candida albicans is an important human fungal pathogen. Resistance to all major antifungal agents has been observed in clinical isolates of Candida spp. and is a major clinical challenge. The rise and expansion of drug-resistant mutants during exposure to antifungal agents occurs through a process of adaptive evolution, with potentially complex population dynamics. Understanding the population dynamics during the emergence of drug resistance is important for determining the fundamental principles of how fungal pathogens evolve for resistance. While few detailed reports that focus on the population dynamics of C. albicans currently exist, several important features on the population structure and adaptive landscape can be elucidated from existing evolutionary studies in in vivo and in vitro systems.
© 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540673     DOI: 10.1111/j.1574-6968.2012.02587.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

1.  Stable synthetic mono-substituted cationic bacteriochlorins mediate selective broad-spectrum photoinactivation of drug-resistant pathogens at nanomolar concentrations.

Authors:  Liyi Huang; Michael Krayer; John G S Roubil; Ying-Ying Huang; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  J Photochem Photobiol B       Date:  2014-10-05       Impact factor: 6.252

2.  In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species.

Authors:  Arjuna N B Ellepola; Rachel Chandy; Zia U Khan
Journal:  Med Princ Pract       Date:  2016-04-23       Impact factor: 1.927

3.  Application of 460 nm visible light for the elimination of Candida albicans in vitro and in vivo.

Authors:  Chuan Wang; Zhiyin Yang; Yinbo Peng; Yuanyuan Guo; Min Yao; Jiying Dong
Journal:  Mol Med Rep       Date:  2018-06-20       Impact factor: 2.952

Review 4.  Effects of Propolis on Infectious Diseases of Medical Relevance.

Authors:  Nelly Rivera-Yañez; C Rebeca Rivera-Yañez; Glustein Pozo-Molina; Claudia F Méndez-Catalá; Julia Reyes-Reali; María I Mendoza-Ramos; Adolfo R Méndez-Cruz; Oscar Nieto-Yañez
Journal:  Biology (Basel)       Date:  2021-05-12

5.  Role of Ess1 in growth, morphogenetic switching, and RNA polymerase II transcription in Candida albicans.

Authors:  Dhanushki Samaranayake; David Atencio; Randall Morse; Joseph T Wade; Vishnu Chaturvedi; Steven D Hanes
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

6.  Filamentation protects Candida albicans from amphotericin B-induced programmed cell death via a mechanism involving the yeast metacaspase, MCA1.

Authors:  David J Laprade; Melissa S Brown; Morgan L McCarthy; James J Ritch; Nicanor Austriaco
Journal:  Microb Cell       Date:  2016-07

7.  Changes in the cell surface hydrophobicity of oral Candida albicans from smokers, diabetics, asthmatics, and healthy individuals following limited exposure to chlorhexidine gluconate.

Authors:  Arjuna N B Ellepola; Bobby K Joseph; Z U Khan
Journal:  Med Princ Pract       Date:  2012-12-18       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.